M&A

Morphic kept it simple in M&A maneuvers, staying focused on Lilly to reel in $3.2B buyout
Fierce Biotech
Fri, 07/19/24 - 11:54 am
Morphic
Eli Lilly
M&A
Exscientia pays $20M for full control of CDK7 drug, plans breast cancer combo trial
Fierce Biotech
Thu, 07/18/24 - 11:10 am
Exscientia
GT Apeiron
M&A
breast cancer
GTAEXS617
Johnson & Johnson boosts full-year outlook on strong Q2 sales numbers
Medical Marketing and Media
Wed, 07/17/24 - 12:00 pm
J&J
M&A
earnings
J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer
Fierce Pharma
Mon, 07/15/24 - 11:20 pm
CAR-T
Legend Biotech
M&A
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
BioSpace
Mon, 07/15/24 - 09:51 am
Sino Biological
SignalChem Biotech
M&A
COVID R&D Alliance
Illumina buys Fluent Biosciences, adding single-cell analysis tech
Yahoo Finance
Wed, 07/10/24 - 04:57 pm
Medtech
Illumina
M&A
Fluent Biosciences
Thermo Fisher Scientific Completes Olink Acquisition
Contract Pharma
Wed, 07/10/24 - 04:55 pm
Thermo Fisher Scientific
Olink
M&A
medtehc
Proteomics
STAAR Surgical gains amid takeover speculation
Seeking Alpha
Wed, 07/10/24 - 04:45 pm
Medtech
M&A
Staar Surgical
Alcon
Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster
Fierce Biotech
Mon, 07/8/24 - 11:54 am
Eli Lilly
Morphic
M&A
Takeda
Entyvio
IBD
Medtech M&A may pick up after mixed start to 2024, analysts
Medtech Dive
Mon, 07/1/24 - 11:16 am
Medtech
M&A
Radionetics Oncology Enters Into Strategic Agreement With Lilly
Businesswire
Mon, 07/1/24 - 11:16 am
Eli Lilly
Radionetics Oncology
radiopharmaceuticals
M&A
Future Pak withdraws offer to buy Vanda Pharmaceuticals
Reuters
Thu, 06/27/24 - 11:32 am
M&A
Vanda Pharmaceuticals
Future Pak
AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave
Fierce Biotech
Thu, 06/27/24 - 11:27 am
AbbVie
M&A
Celsius Therapeutics
Sanofi Seeks Initial Offers for Its $20 Billion Consumer Arm
Yahoo/Bloomberg
Tue, 06/25/24 - 09:13 pm
Sanofi
M&A
consumer health
Biopharma dealmaking continues to rise, but M&A values hold steady: PwC
Fierce Biotech
Thu, 06/20/24 - 11:43 am
M&A
PwC
Vanda rejects buyout offers, pans 'opportunistic attempts' at securing its shares at a discount
Fierce Pharma
Thu, 06/20/24 - 11:42 am
Vanda Pharmaceuticals
M&A
CDMOs
Future Pak
Cycle Pharmaceuticals
Boston Scientific Weaves a $1.16B Acquisition
Medical Devices and Diagnostics Industry
Tue, 06/18/24 - 07:54 pm
Boston Scientific
Medtech
M&A
Silk Road Medical
TCAR
Biogen’s HI-Bio Buy Is Latest Biopharma Spending Spree in Projected $257B Immunology Market
BioSpace
Wed, 06/12/24 - 11:09 am
Biogen
Hi-Bio
M&A
After M&A stretch, Pfizer CEO says company needs 'breathing period' from large deals
Fierce Pharma
Tue, 06/11/24 - 11:41 am
Pfizer
Albert Bourla
Pharma CEOs
M&A
As biotech recovers, venture firms’ preferences appear to shift
BioPharma Dive
Fri, 06/7/24 - 11:26 am
funding
biotech
venture capital
M&A
IPOs

Pages